Population Screening for Colorectal Cancer Means Getting FIT: The Past, Present, and Future of Colorectal Cancer Screening Using the Fecal Immunochemical Test for Hemoglobin (FIT)

被引：143
作者：
Allison, James E. [1 ,2 ]
Fraser, Callum G. [3 ]
Halloran, Stephen P. [4 ,5 ]
Young, Graeme P. [6 ]
机构：
[1] Univ Calif San Francisco, Sch Med, Div Gastroenterol, San Francisco, CA 94110 USA
[2] Kaiser Permanente No Calif, Div Res, Oakland, CA USA
[3] Univ Dundee, Ctr Res Canc Prevent & Screening, Sch Med, Dundee, Scotland
[4] Royal Surrey Cty Hosp, NHS Bowel Canc Screening Southern Programme Hub, Guildford, Surrey, England
[5] Univ Surrey, Guildford GU2 5XH, Surrey, England
[6] Flinders Univ S Australia, Flinders Ctr Innovat Canc, Bedford Pk, SA 5042, Australia
来源：
GUT AND LIVER | 2014年 / 8卷 / 02期
关键词：
Population screening; Colorectal cancer; Fecal immunochemical test for hemoglobin; Colorectal cancer screening; OCCULT-BLOOD-TESTS; RANDOMIZED CONTROLLED-TRIAL; AMERICAN-COLLEGE; PARTICIPATION; RISK; COLONOSCOPY; PERFORMANCE; SIGMOIDOSCOPY; MORTALITY; IMPROVES;
D O I：
10.5009/gnl.2014.8.2.117
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Fecal immunochemical tests for hemoglobin (FIT) are changing the manner in which colorectal cancer (CRC) is screened. Although these tests are being performed worldwide, why is this test different from its predecessors? What evidence supports its adoption? How can this evidence best be used? This review addresses these questions and provides an understanding of FIT theory and practices to expedite international efforts to implement the use of FIT in CRC screening.
引用
收藏
页码：117 / 130
页数：14
相关论文
共 86 条
  • [1] Colorectal cancer screening by detection of altered human DNA in stool: Feasibility of a multitarget assay panel
    Ahlquist, DA
    Skoletsky, JE
    Boynton, KA
    Harrington, JJ
    Mahoney, DW
    Pierceall, WE
    Thibodeau, SN
    Shuber, AP
    [J]. GASTROENTEROLOGY, 2000, 119 (05) : 1219 - 1227
  • [2] Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics
    Allison, James E.
    Sakoda, Lori C.
    Levin, Theodore R.
    Tucker, Jo P.
    Tekawa, Irene S.
    Cuff, Thomas
    Pauly, Mary Pat
    Shlager, Lyle
    Palitz, Albert M.
    Zhao, Wei K.
    Schwartz, J. Sanford
    Ransohoff, David F.
    Selby, Joseph V.
    [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2007, 99 (19): : 1462 - 1470
  • [3] Comparing Fecal Immunochemical Tests: Improved Standardization Is Needed
    Allison, James E.
    Fraser, Callum G.
    Halloran, Stephen P.
    Young, Graeme P.
    [J]. GASTROENTEROLOGY, 2012, 142 (03) : 422 - 424
  • [4] The Imperative of Equal Funding for Studies That Evaluate Any of the Evidence-Based, Guideline-Recommended Colorectal Cancer Screening Tests
    Allison, James E.
    [J]. CLINICAL GASTROENTEROLOGY AND HEPATOLOGY, 2009, 7 (12) : 1269 - 1271
  • [5] A comparison of fecal occult-blood tests for colorectal-cancer screening
    Allison, JE
    Tekawa, IS
    Ransom, LJ
    Adrain, AL
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (03) : 155 - 159
  • [6] [Anonymous], CA CANC J CLIN, DOI DOI 10.3322/CAAC.20107
  • [7] Once-only flexible sigmoidoscopy screening in prevention of colorectal cancer: a multicentre randomised controlled trial
    Atkin, Wendy S.
    Edwards, Rob
    Kralj-Hans, Ines
    Wooldrage, Kate
    Hart, Andrew R.
    Northover, John M. A.
    Parkin, D. Max
    Wardle, Jane
    Duffy, Stephen W.
    Cuzick, Jack
    [J]. LANCET, 2010, 375 (9726) : 1624 - 1633
  • [8] BARROWS GH, 1978, AM J CLIN PATHOL, V69, P342
  • [9] Sex Differences in Performance of Fecal Occult Blood Testing
    Brenner, Hermann
    Haug, Ulrike
    Hundt, Sabrina
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2010, 105 (11) : 2457 - 2464
  • [10] MONITORING FAECAL OCCULT BLOOD TEST POSITIVITY IN THE NHS BOWEL CANCER SCREENING PROGRAMME
    Burtonwood, C.
    Butler, P.
    Young, M.
    Halloran, S.
    [J]. GUT, 2012, 61 : A334 - A334
123456789